Cadila gets nod for H1N1 vaccine in India

MUMBAI Wed May 12, 2010 12:05pm IST

A man walks past a graffiti about H1N1 influenza on a street side wall in Mumbai September 9, 2009. Cadila Healthcare Ltd said on Wednesday it has received approval from the Drug Controller General of India to market the H1N1 vaccine in the country.  REUTERS/Arko Datta/Files

A man walks past a graffiti about H1N1 influenza on a street side wall in Mumbai September 9, 2009. Cadila Healthcare Ltd said on Wednesday it has received approval from the Drug Controller General of India to market the H1N1 vaccine in the country.

Credit: Reuters/Arko Datta/Files

Related Topics

MUMBAI (Reuters) - Cadila Healthcare Ltd said on Wednesday it has received approval from the Drug Controller General of India (DCGI) to market its H1N1 vaccine in the country.

Used to prevent the infection of swine flu, this egg-based vaccine named 'VaxiFlu-S' will be marketed by Vaxxicare, a division of the company, it said in a statement.

Indian drumakers such as Panacea Biotec and Pune-based unlisted vaccines maker Serum Institute are also close to launch an H1N1 vaccine in the country.

Out of the 139,466 people tested for swine flu symptoms in India since the outbreak of the pandemic in the year 2009, about 23 percent have tested positive for swine flu, Cadila said in a statement.

"The development is positive for the company as India has a huge population of people aged above 60 years and below 15 years," a pharma sector analyst told Reuters over the telephone.

"While Panacea Biotec is looking to sell the vaccine to the government, Cadila has a focus on direct domestic market. This would help company make early in-roads," another analyst said.

The market size for H1N1 vaccine in India in case of high-risk population was about 4-5 million doses, Pankaj Patel, chairman and managing director of Cadila had told Reuters.

Cadila also plans to develop more vaccines against bacterial, viral and protozoal infections at its vaccine technology centre, it said in the statement.

At 11:32 a.m., shares of Cadila Healthcare were trading at 586 rupees, up 1.97 percent in a flat Mumbai market.

(Reporting by Kaustubh Kulkarni, Editing by Ramya Venugopal)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Markets

REUTERS SHOWCASE

Modi's 100 Days

Modi's 100 Days

100 days of Modi: Good for business, not so good for marginalised groups  Full Article 

India Win

India Win

India crush feeble England to clinch one-day series.  Full Article 

Power Outage

Power Outage

Mumbai hit by power cuts  Full Article 

Segway in India

Segway in India

Segway’s India business pegs hope on tech-savvy Modi   Full Article 

Pakistan Protests

Pakistan Protests

Pakistan parliament backs embattled prime minister as crisis deepens  Full Article 

Afghan Turmoil

Afghan Turmoil

Afghan turmoil threatens NATO's "mission accomplished" plans  Full Article 

In Trouble

In Trouble

Justin Bieber charged with assault, dangerous driving in Canada.  Full Article 

Mass Hacking

Mass Hacking

Actress Jennifer Lawrence contacts authorities after nude photos hacked.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage